James L. Wade

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

Thomas J. Smith, James Khatcheressian, Gary H. Lyman et al. · Journal of Clinical Oncology · 2006 · 1.6K citations · Full text

Medicine, Hematology, Oncology +17

2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

Howard Ozer, Jamés O. Armitage, Charles L. Bennett et al. · Journal of Clinical Oncology · 2000 · 1K citations

Medicine, Hematology, Oncology +8

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

George D. Demetri, Mark G. Kris, James L. Wade et al. · Journal of Clinical Oncology · 1998 · 756 citations

Medicine, Oncology, Pharmacology +12

Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer

Victor G. Vogel, Joseph P. Costantino, D. Lawrence Wickerham et al. · Cancer Prevention Research · 2010 · 639 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15